1. WHO. Global tuberculosis report 2017. Report. Geneva: WHO institute; 2017 October.
2. Prevots DR, Loddenkemper R, Sotgiu G, Migliori GB. Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs. Eur Respir J. 2017;49(4) pii: 1700374. doi: 10.1183/1399300 3.00374-2017.
3. Food and Drug Administration. Microbiology device, reclassification of nucleic acid-based systems for Mycobacterium tuberculosis complex. Report. Washington: Department of Health and Human Service; 2013 Jan.
4. Food and Drug Administration. Microbiology device. Class II special controls guideline: nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex in respiratory specimens. Report. Washington: Department of Health and Human Service; 2014 May.
5. Food and Drug Administration. Department of Health and Human service. Microbiology Device. Class II special controls guideline: nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex and genetic mutations associated with Mycobacterium tuberculosis complex antibiotic resistance in respiratory specimens. Report. Washington: Department of Health and Human Service; 2014 October.